COVID-19 Personal Protective Equipment for Vaccinated Health Workers and Convalescents
- Conditions
- Covid19
- Interventions
- Other: Personal Protective Equipment
- Registration Number
- NCT06158724
- Lead Sponsor
- University Medical Centre Ljubljana
- Brief Summary
The aim of the trial is to assess the safety of using simplified personal protective equipment (PPE) for vaccinated or COVID-19 convalescent healthcare workers working in COVID-19 ICU or COVID-19 wards.
The trial is designed as a prospective randomized observational trial with volunteer medical staff working in COVID-19 departments aiming to show non-inferiority of simplified PPE vs standard COVID-19 PPE.
- Detailed Description
Objectives To assess safety of simplified personal protective equipment (PPE) for vaccinated health workers and COVID-19 convalescents - pilot trial.
Methods Prospective randomized observational trial. 60 participants randomized 1:1 to either standard PPE (COVID-19 ward: FFP2 or higher respirator, goggles of face shield, gown, gloves; COVID-19 ICU: FFP3 respirator and tight goggles or full face mask or powered air-purifying respirators, gown and gloves) or simplified PPE (surgical mask, goggles or face shield, gown). 30 days follow up period.
Participants Volunteer medical staff from COVID-19 regular and ICU departments at University Medical Center Ljubljana, Slovenia, with either proven COVID-19 infection within 6 months or at least 7 days after second dose anti COIVD-19 vaccine.
Hypotheses Simplified PPE is non-inferior to standard PPE in vaccinated health workers or convalescents.
Discussion Positive study results may decrease PPE spending cost and positively affect working conditions at COVID-19 departments.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- age < 50 years
- prior COVID-19 infection; time from infection < 6 months.
- prior completed anti COVID-19 immunization; > 1 week post second dose of immunization.
- signed written consent
- negative nasopharyngeal COVID-19 RT-PCR test
- age > 50 years
- time post COVID-19 infection > 6 months
- time post COVID-19 immunization < 1 week.
- immunocompromised patients
- pregnancy
- CKD 3 or more
- COPD or other lung disease
- heart failure of any cause
- ischemic heart disease
- obesity (BMI > 30)
- DM on therapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Simplified PPE group Personal Protective Equipment Surgical mask, standard non sealing goggles, use of protective gown while in direct contact with patients.
- Primary Outcome Measures
Name Time Method Non-inferiority of simplified PPE compared to standard PPE regarding symptomatic infection rate. 30 days The use of simplified PPE will not predispose COVID-19 immune healthcare workers to symptomatic neoinfection.
- Secondary Outcome Measures
Name Time Method Non-inferiority of simplified PPE compared to standard PPE regarding asymptomatic infection rate. 30 days No difference in nasopharyngeal RT-PCR SARS-CoV 2 results between groups.
Rise in anti-SARS-CoV 2 antibody titers in the simplified PPE group. 30 days
Trial Locations
- Locations (1)
University Medical Center Ljubljana
🇸🇮Ljubljana, Slovenia